| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/24/1997 | EP0796272A1 Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application |
| 09/24/1997 | EP0796271A1 New dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals |
| 09/24/1997 | EP0796270A2 Peptide compounds for prevention and/or treatment of no-mediated diseases |
| 09/24/1997 | EP0796257A1 Malonic acid based matrix metalloproteinase inhibitors |
| 09/24/1997 | EP0796115A1 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 09/24/1997 | EP0796113A2 Stable n-terminally linked dtpa:protein compositions and methods |
| 09/24/1997 | EP0796112A1 Phosphocholine drug derivatives |
| 09/24/1997 | EP0796109A1 Antisense oligonucleotides to suppress eicosanoid formation |
| 09/24/1997 | EP0796106A1 Protracted glp-1 compositions |
| 09/24/1997 | EP0796105A1 Pharmaceutical compositions for the treatment of autoimmune diseases comprising the b-oligomer of pertussis toxin or its subunits |
| 09/24/1997 | EP0750609A4 Isoprenyl transferase inhibitors |
| 09/24/1997 | EP0636143B1 Alpha-aminoboronic acid peptides and their use as elastase inhibitors |
| 09/24/1997 | EP0617705B1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them |
| 09/24/1997 | EP0606463A4 Neuromedin b receptor antagonists. |
| 09/24/1997 | EP0584374B1 Peptide which inhibits phospholipase c |
| 09/24/1997 | EP0563385B1 Thrombolytic peptide, production thereof and thrombolytic agent |
| 09/24/1997 | EP0521985B1 Chimeric antibodies with receptor binding ligands in place of their constant region |
| 09/24/1997 | CN1160355A Stable, aqueous alpha interferon solution formulations |
| 09/24/1997 | CN1160345A Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
| 09/24/1997 | CN1159950A Bioadhesive pharmaceutical composition for controlled release of active principles |
| 09/24/1997 | CN1159949A Use of peptide compounds and pharmaceutically acceptable salts thereof for manufacturing medicament for treating diseases |
| 09/24/1997 | CN1159918A Method for preparing anticancer bioactive peptide preparation |
| 09/23/1997 | US5670699 Process for preparing amino acid esters useful as intermediates for compounds containing a fused bicyclic ring |
| 09/23/1997 | US5670675 Retroviral protease inhibiting compounds |
| 09/23/1997 | US5670634 Inhibit expression of peptide of alzheimer's disease and down's syndrome |
| 09/23/1997 | US5670633 Sugar modified oligonucleotides that detect and modulate gene expression |
| 09/23/1997 | US5670626 Allergen-specific human IgA monoclonal antibodies for mucosal administration |
| 09/23/1997 | US5670625 Cell surface protein |
| 09/23/1997 | US5670623 Methods of use of cellulose binding domain proteins |
| 09/23/1997 | US5670622 Conotoxin peptide PIIIA |
| 09/23/1997 | US5670621 Selectively recognizes and binds dna damaged by a drug |
| 09/23/1997 | US5670619 Bradykinin-antagonists for the treatment of acute pancreatitis |
| 09/23/1997 | US5670618 Isolated from saccharomyces |
| 09/23/1997 | US5670617 Nucleic acid conjugates of tat-derived transport polypeptides |
| 09/23/1997 | US5670537 Method for effecting tumor regression with a low dose, short infusion taxol regimen |
| 09/23/1997 | US5670517 Multistage synthesis with epoxidation, decarbonylation, coupling by amidation then decarbonylation |
| 09/23/1997 | US5670504 2,6-diaryl pyridazinones with immunosuppressant activity |
| 09/23/1997 | US5670494 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors |
| 09/23/1997 | US5670488 Adenovirus vector for gene therapy |
| 09/23/1997 | US5670484 Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders |
| 09/23/1997 | US5670482 Neuropeptide Y antagonists |
| 09/23/1997 | US5670481 Dorsal tissue affecting factor (noggin) and compositions comprising same |
| 09/23/1997 | US5670480 Method of making polymers having specific properties |
| 09/23/1997 | US5670479 α-ketoamide derivatives as inhibitors of thrombosis |
| 09/23/1997 | US5670478 Cyclosporins |
| 09/23/1997 | US5670477 Method to enhance permeability of the blood/brain blood/nerve bariers to therapeutic agents |
| 09/23/1997 | US5670373 Binding to human interleukin-6 receptors |
| 09/23/1997 | US5670361 HIV-specific ribozymes |
| 09/23/1997 | US5670354 Use of VSV-G pseudotyped vectors for transfer of genes into embryos |
| 09/23/1997 | US5670342 Stimulate the proliferation and differentiation of colon epithelial cells |
| 09/23/1997 | US5670341 DNA vectors, hosts, probes and recombinant methods of preparing human somatomedin-like carrier proteins or polypeptides |
| 09/23/1997 | US5670338 Genetic engineering; therapy for osteoporosis |
| 09/23/1997 | US5670337 Polymorphism of human platelet membrane glycoprotein IIIa and diagnostic and therapeutic applications thereof |
| 09/23/1997 | US5670336 Method for recombinant production of osteogenic protein |
| 09/23/1997 | US5670335 Mammalian inward rectifier potasssium channel cDNAs, host cells expressing them, and screening assays using such cells |
| 09/23/1997 | US5670310 Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection |
| 09/23/1997 | US5670173 Biodegradable polymer membrane containing hemoglobin for blood substitute |
| 09/23/1997 | US5670166 Pharmaceutical formulation and process |
| 09/23/1997 | US5670155 Confomationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| 09/23/1997 | US5670153 Immunoreactive polypeptide compositions |
| 09/23/1997 | US5670152 Containing hepatitis virus epitopes |
| 09/23/1997 | US5670150 Non-depleting CD4-specific monoclonal antibodies for the treatment of insulin-dependent diabetes mellitus (IDDM) |
| 09/23/1997 | US5670149 Lymphotoxin-β, Lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
| 09/23/1997 | US5670148 Combined cellular and immunosuppressive therapies |
| 09/23/1997 | US5670146 Pharmacological preparations comprising human pluripotent hematopoietic colony stimulating factor |
| 09/23/1997 | US5670142 Topical application of an enzyme from the group papain, pancreatin and subtilisin in combination with an antibiotic; reduction of pruritus and scarring |
| 09/23/1997 | US5670133 Chemotactic peptide containing labeled metal binding ions |
| 09/23/1997 | US5669396 Blood test; using antibodies |
| 09/23/1997 | CA1339477C Gel filtration of factor viii |
| 09/22/1997 | CA2200163A1 Antithrombotic diamides |
| 09/20/1997 | CA2200394A1 A pharmaceutical preparation for treating blood coagulation disorders |
| 09/18/1997 | WO1997034146A1 Inhibiting protein interactions |
| 09/18/1997 | WO1997034137A2 Methods of the identification of pharmaceutically active compounds |
| 09/18/1997 | WO1997034013A1 Chemotactic cytokine ii |
| 09/18/1997 | WO1997034002A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | WO1997034001A1 Clostridium perfringens vaccines |
| 09/18/1997 | WO1997033999A1 Immunity to trypanosomatids species |
| 09/18/1997 | WO1997033998A1 Targeted delivery of genes encoding interferon |
| 09/18/1997 | WO1997033997A1 Method of treating muscular disorders |
| 09/18/1997 | WO1997033996A2 Human bikunin |
| 09/18/1997 | WO1997033995A2 Extracellular matrix signalling molecules |
| 09/18/1997 | WO1997033993A1 Human membrane antigen tm4 superfamily protein and dna encoding this protein |
| 09/18/1997 | WO1997033992A1 Selected oligonucleotides with anti-cytomegalovirus activity |
| 09/18/1997 | WO1997033991A1 Short external guide sequences |
| 09/18/1997 | WO1997033990A1 Regulatory element for interleukin-5 |
| 09/18/1997 | WO1997033986A1 Arginase ii |
| 09/18/1997 | WO1997033985A1 Arginase ii |
| 09/18/1997 | WO1997033980A1 Transgenic animals having a disrupted endothelial nitric oxide synthase gene and methods of use |
| 09/18/1997 | WO1997033916A1 Monoclonal antibodies ior c5 for the diagnosis and treatment of colorectal tumors |
| 09/18/1997 | WO1997033915A1 Avian, vitellin antibodies directed against hiv antigens |
| 09/18/1997 | WO1997033914A1 Methods for producing hemoglobin preparations and preparations obtainable thereby |
| 09/18/1997 | WO1997033913A1 Cytokine-receptor expressed in testis cells |
| 09/18/1997 | WO1997033912A2 Uses of gdnf and gdnf receptor |
| 09/18/1997 | WO1997033911A1 Persephin and related growth factors |
| 09/18/1997 | WO1997033910A1 Immunomodulatory peptides of vespid antigen 5 |
| 09/18/1997 | WO1997033908A1 Lytic peptides |
| 09/18/1997 | WO1997033907A1 Peptide derivatives |
| 09/18/1997 | WO1997033904A1 Death domain containing receptors |
| 09/18/1997 | WO1997033903A1 HUMAN MutY |
| 09/18/1997 | WO1997033902A1 Human tumor necrosis factor delta and epsilon |